A silent mutation in mabA confers isoniazid resistance on Mycobacterium tuberculosis

Molecular Microbiology

Volumn 91, Issue 3, 2014, Pages 538-547

  Ando, Hiroki ^a,b   Miyoshi Akiyama, Tohru ^a   Watanabe, Shinya ^a   Kirikae, Teruo ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; BACTERIAL PROTEIN; INHA PROTEIN, MYCOBACTERIUM; OXIDOREDUCTASE; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE CONTROL; GENE MUTATION; INHA GENE; MABA GENE; MINIMUM INHIBITORY CONCENTRATION; MUTATIONAL ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; UPREGULATION; BIOSYNTHESIS; DNA SEQUENCE; DRUG EFFECT; GENE EXPRESSION; GENETICS; HUMAN; MICROBIOLOGY; MOLECULAR GENETICS; POINT MUTATION; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION; HUMANS; ISONIAZID; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASES; POINT MUTATION; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS; UP-REGULATION;

EID: 84908105255     PISSN: 0950382X     EISSN: 13652958     Source Type: Journal    
DOI: 10.1111/mmi.12476     Document Type: Article

References (33)

1. Alland, D., Steyn, A.J., Weisbrod, T., Aldrich, K., and Jacobs, W.R., Jr (2000) Characterization of the Mycobacterium tuberculosis iniBAC promoter, a promoter that responds to cell wall biosynthesis inhibition. J Bacteriol 182: 1802-1811.
2. Ando, H., Kondo, Y., Suetake, T., Toyota, E., Kato, S., Mori, T., and Kirikae, T. (2010) Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 54: 1793-1799.
3. Ando, H., Kitao, T., Miyoshi-Akiyama, T., Kato, S., Mori, T., and Kirikae, T. (2011) Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis. Mol Microbiol 79: 1615-1628.
4. Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K.S., Wilson, T., etal. (1994) inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263: 227-230.
5. Banerjee, A., Sugantino, M., Sacchettini, J.C., and Jacobs, W.R. (1998) The mabA gene from the inhA operon of Mycobacterium tuberculosis encodes a 3-ketoacyl reductase that fails to confer isoniazid resistance. Microbiology 144 (Pt 10): 2697-2704.
6. Bardarov, S., Bardarov, S. Jr, Pavelka, M.S. Jr, Sambandamurthy, V., Larsen, M., Tufariello, J., etal. (2002) Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M.bovis BCG and M. smegmatis. Microbiology 148: 3007-3017.
7. Bernstein, J., Lott, W.A., Steinberg, B.A., and Yale, H.L. (1952) Chemotherapy of experimental tuberculosis. V. Isonicotinic acid hydrazide (nydrazid) and related compounds. Am Rev Tuberc 65: 357-364.
8. Buchmeier, N.A., Newton, G.L., Koledin, T., and Fahey, R.C. (2003) Association of mycothiol with protection of Mycobacterium tuberculosis from toxic oxidants and antibiotics. Mol Microbiol 47: 1723-1732.
9. Cui, X., and Churchill, G.A. (2003) Statistical tests for differential expression in cDNA microarray experiments. Genome Biol 4: 210.
10. Espinal, M.A., Laszlo, A., Simonsen, L., Boulahbal, F., Kim, S.J., Reniero, A., etal. (2001) Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 344: 1294-1303.
11. Hazbon, M.H., Brimacombe, M., Bobadilla del Valle, M., Cavatore, M., Guerrero, M.I., Varma-Basil, M., etal. (2006) Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 50: 2640-2649.
12. Heym, B., Stavropoulos, E., Honore, N., Domenech, P., Saint-Joanis, B., Wilson, T.M., etal. (1997) Effects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis. Infect Immun 65: 1395-1401.
13. Kal, A.J., van Zonneveld, A.J., Benes, V., van den Berg, M., Koerkamp, M.G., Albermann, K., etal. (1999) Dynamics of gene expression revealed by comparison of serial analysis of gene expression transcript profiles from yeast grown on two different carbon sources. Mol Biol Cell 10: 1859-1872.
14. Larsen, M.H., Vilcheze, C., Kremer, L., Besra, G.S., Parsons, L., Salfinger, M., etal. (2002) Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M.bovis BCG and M.tuberculosis. Mol Microbiol 46: 453-466.
15. Lee, J.H., Ammerman, N.C., Nolan, S., Geiman, D.E., Lun, S., Guo, H., and Bishai, W.R. (2012) Isoniazid resistance without a loss of fitness in Mycobacterium tuberculosis. Nat Commun 3: 753.
16. Mitarai, S., Kato, S., Ogata, H., Aono, A., Chikamatsu, K., Mizuno, K., etal. (2012) Comprehensive multicenter evaluation of a new line probe assay kit for identification of Mycobacterium species and detection of drug-resistant Mycobacterium tuberculosis. J Clin Microbiol 50: 884-890.
17. Mortazavi, A., Williams, B.A., McCue, K., Schaeffer, L., and Wold, B. (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5: 621-628.
18. Otsuka, Y., Parniewski, P., Zwolska, Z., Kai, M., Fujino, T., Kirikae, F., etal. (2004) Characterization of a trinucleotide repeat sequence (CGG)5 and potential use in restriction fragment length polymorphism typing of Mycobacterium tuberculosis. J Clin Microbiol 42: 3538-3548.
19. Ramaswamy, S., and Musser, J.M. (1998) Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 79: 3-29.
20. Ramaswamy, S.V., Reich, R., Dou, S.J., Jasperse, L., Pan, X., Wanger, A., etal. (2003) Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 47: 1241-1250.
21. Ramaswamy, S.V., Dou, S.J., Rendon, A., Yang, Z., Cave, M.D., and Graviss, E.A. (2004) Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. J Med Microbiol 53: 107-113.
22. Rozwarski, D.A., Grant, G.A., Barton, D.H., Jacobs, W.R., Jr, and Sacchettini, J.C. (1998) Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science 279: 98-102.
23. Sekiguchi, J., Miyoshi-Akiyama, T., Augustynowicz-Kopec, E., Zwolska, Z., Kirikae, F., Toyota, E., etal. (2007) Detection of multidrug resistance in Mycobacterium tuberculosis. J Clin Microbiol 45: 179-192.
24. Timm, J., Lim, E.M., and Gicquel, B. (1994) Escherichia coli-mycobacteria shuttle vectors for operon and gene fusions to lacZ: the pJEM series. J Bacteriol 176: 6749-6753.
25. Vilcheze, C., Weisbrod, T.R., Chen, B., Kremer, L., Hazbon, M.H., Wang, F., etal. (2005) Altered NADH/NAD+ ratio mediates coresistance to isoniazid and ethionamide in mycobacteria. Antimicrob Agents Chemother 49: 708-720.
26. Vilcheze, C., Wang, F., Arai, M., Hazbon, M.H., Colangeli, R., Kremer, L., etal. (2006) Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. Nat Med 12: 1027-1029.
27. Vilcheze, C., Av-Gay, Y., Attarian, R., Liu, Z., Hazbon, M.H., Colangeli, R., etal. (2008) Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis. Mol Microbiol 69: 1316-1329.
28. Vilcheze, C., Av-Gay, Y., Barnes, S.W., Larsen, M.H., Walker, J.R., Glynne, R.J., and Jacobs, W.R., Jr (2011) Coresistance to isoniazid and ethionamide maps to mycothiol biosynthetic genes in Mycobacterium bovis. Antimicrob Agents Chemother 55: 4422-4423.
29. Wang, F., Jain, P., Gulten, G., Liu, Z., Feng, Y., Ganesula, K., etal. (2010) Mycobacterium tuberculosis dihydrofolate reductase is not a target relevant to the antitubercular activity of isoniazid. Antimicrob Agents Chemother 54: 3776-3782.
30. World Health Organization (2013) Global Tuberculosis Report 2013. Geneva: WHO Press.
31. Zhang, M., Yue, J., Yang, Y.P., Zhang, H.M., Lei, J.Q., Jin, R.L., etal. (2005) Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China. J Clin Microbiol 43: 5477-5482.
32. Zhang, Y., and Yew, W.W. (2009) Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 13: 1320-1330.
33. Zhang, Y., Heym, B., Allen, B., Young, D., and Cole, S. (1992) The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358: 591-593.